Tsingke Biotech Shines at Cell & Gene Therapy International
Engaging with Global Leaders
Beijing Tsingke Biotech Co., Ltd. recently participated in a prominent exhibition that welcomed thousands of professionals in the cell and gene therapy sector. This event served as a remarkable platform for Tsingke to demonstrate its cutting-edge technologies and solutions aimed at revolutionizing biopharmaceutical practices worldwide.
Highlights from the Exhibition
The event attracted an impressive number of attendees from leading biopharma companies, positioning Tsingke at the heart of impactful conversations around advancements in cell and gene therapy. Engaging directly with scientists and researchers, Tsingke’s team exchanged insightful discussions about how the company’s products can support various research initiatives.
Innovative Product Offerings
Tsingke showcased a range of products that have drawn significant interest. Their self-developed synthetic materials and bioreagents have generated positive feedback regarding their reliability and efficiency. Researchers were particularly thrilled with the company’s gene synthesis, oligomer synthesis, and virus packaging solutions, which facilitate faster and more accurate results in scientific research.
Deep Dive into Product Solutions
Gene Synthesis: Tsingke’s gene synthesis services are instrumental across several fields, including life science research and biopharmaceutical development. The company offers high-quality plasmids up to 200kb in length through its intelligent synthesis line, focusing on customer needs and optimizing their project timelines.
With complimentary codon optimization services and thorough quality checks including NGS and Sanger sequencing, researchers can rely on Tsingke to deliver exceptionally crafted synthetic genes swiftly, often within just five days.
Oligo Synthesis: Specializing in high-grade modified Oligo products, Tsingke provides a wide array of options suitable for various applications like diagnostics and drug discovery. This versatility is reflected in the scale of production, ranging from micrograms to kilograms, allowing for both research and industrial applications.
With the assurance of ISO 13485 certification and state-of-the-art workshops, Tsingke guarantees the purity and reliability of its product offerings, making it a trusted partner for over 1,200 companies in the biotechnology space.
Structured Virus Packaging Solutions
Tsingke’s commitment to innovative practices extends to its virus packaging services. Having established a Biosafety Level 2 laboratory, the company is well-equipped to handle the development and production of diverse viral vectors. Their wide range of viral products, including Lentivirus and Adenovirus, undergoes strict quality controls to ensure safety and efficacy in various applications.
Researchers can rest assured that Tsingke’s products not only meet high standards for safety and purity but also support long-term gene expression necessary for successful experimentation.
Company Commitment to Innovation
Beijing Tsingke Biotech Co., Ltd. is a leading entity in DNA and RNA synthesis, dedicated to pushing the boundaries of biotechnological innovation. The company thrives on a mission to contribute positively to global health and research through its advanced synthesis platform.
This facility covers an expansive area equipped with the latest technology, reinforcing Tsingke’s stronghold on intellectual property with over 300 rights. Their reputation for delivering high-quality products and comprehensive service has cultivated a loyal clientele, surpassing 300,000 satisfied customers worldwide.
Looking Ahead
As Tsingke concludes its successful participation in the exhibition, it eagerly anticipates fostering new collaborations and advancing its products further, thus continuing to enrich the global life sciences community.
Frequently Asked Questions
What events did Tsingke recently participate in?
Tsingke recently exhibited at the Cell & Gene Therapy International 2024 event in Boston.
What are Tsingke's main products?
Tsingke specializes in gene synthesis, oligo synthesis, and virus packaging, providing comprehensive solutions for biopharmaceutical needs.
How does Tsingke ensure the quality of its products?
Tsingke implements rigorous quality controls, including NGS and Sanger sequencing, to ensure high standards for its synthesized products.
How large is Tsingke's R&D facility?
The company's R&D facility spans approximately 12,000 square meters, featuring state-of-the-art production capabilities.
What is Tsingke's mission?
Tsingke is committed to advancing biotechnology for better global health, emphasizing innovation and comprehensive service in its offerings.
